Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
2 pending office actions • 2 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready • 4 patents granted in the last 365 days
Samyang Holdings Corporation maintains 2 pending office actions within the Biotechnology & Pharmaceuticals technology area. The prosecution workload is spread across 2 distinct examiners and 2 distinct art units. The 2 distinct art units suggest multiple technical classifications for the company's biotechnology filings, indicating a variety of research areas. The assigned art units represent the total count of such divisions involved in the company's current prosecution.
The busiest examiner, NGUYEN, NGOC-ANH THI, is responsible for 1 busiest examiner pending office action. With 2 pending office actions and 2 distinct examiners, the workload is distributed among the assigned officials. The 1 busiest examiner pending office action indicates that the workload is not concentrated under the busiest examiner alone. The distinct examiners confirm that the prosecution is shared across different individuals at the office.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 2 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| NGUYEN, NGOC-ANH THI | 1 | 28.1% | +49.8% |
| JOHNSON, CHRISTOPHER LINDSAY | 1 | 46.9% | +81.0% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18580885 | POWDER FORMULATION FOR TISSUE REPAIR, PREPARATION METHOD THEREFOR, AND INJECTABLE COMPOSITION FOR TISSUE REPAIR, COMPRISING SAME | NGUYEN, NGOC-ANH THI | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18288677 | KIT FOR PREPARING NANOPARTICLES CONTAINING DRUG AND COMPRISING NO AMPHIPHILIC POLYMERS | JOHNSON, CHRISTOPHER LINDSAY | 20d |
| 18580885 | POWDER FORMULATION FOR TISSUE REPAIR, PREPARATION METHOD THEREFOR, AND INJECTABLE COMPOSITION FOR TISSUE REPAIR, COMPRISING SAME | NGUYEN, NGOC-ANH THI | — |
| Art Unit | Apps |
|---|---|
| 1615 | 1 |
| 1691 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18580885 | POWDER FORMULATION FOR TISSUE REPAIR, PREPARATION METHOD THEREFOR, AND INJECTABLE COMPOSITION FOR TISSUE REPAIR, COMPRISING SAME | NGUYEN, NGOC-ANH THI | 1615 | §103 | Non-Final OA | — | Pending | Jan 19, 2024 |
| 18288677 | KIT FOR PREPARING NANOPARTICLES CONTAINING DRUG AND COMPRISING NO AMPHIPHILIC POLYMERS | JOHNSON, CHRISTOPHER LINDSAY | 1691 | §103 | Final Rejection | 20d | Pending | Oct 27, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial